Exhibit 99.1
 
 

 
Align Technology Announces Fourth Quarter and Record Fiscal Year 2012 Results
 
 
SAN JOSE, CA--(Marketwire - January 30, 2013) - Align Technology, Inc. (NASDAQ:
ALGN)
 
•  
2012 net revenues were a record $560.0 million, an increase of 16.7% year-over-year
•  
2012 Invisalign clear aligner case shipments were a record 363.5 thousand, an increase 17.5% year-over-year
•  
Q4 net revenues of $142.8 million include the release of $4.9 million of previously deferred revenue for Invisalign case refinement
•  
Q4 Invisalign clear aligner revenue of $132.8 million increased 4.8% sequentially and 11.7% year-over-year
•  
Q4 Invisalign clear aligner shipments were 90.5 thousand, compared to 92.5 thousand in Q3 12 and 82.6 thousand in Q4 11
•  
Q4 diluted GAAP diluted EPS was $0.12, non-GAAP diluted EPS was $0.27
 
Align Technology, Inc. (NASDAQ: ALGN) today reported financial results for the fourth quarter and fiscal year ended December 31, 2012.
 
Total net revenues for the fourth quarter of fiscal 2012 (Q4 12) were $142.8 million. This is compared to $136.5 million reported in the third quarter of 2012 (Q3 12) and compared to $128.9 million reported in the fourth quarter of 2011 (Q4 11). Q4 12 net revenues include the release of $4.9 million of revenue previously deferred for Invisalign case refinement. Q4 12 Invisalign clear aligner revenue was $132.8 million, compared to $126.7 million in Q3 12 and $118.9 million in Q4 11. Q4 12 Invisalign clear aligner case shipments were 90.5 thousand, compared to 92.5 thousand in Q3 12 and 82.6 thousand in Q4 11. Q4 12 scanner and CAD/CAM services revenue was $10.0 million, compared to $9.8 million in Q3 12 and compared to $10.0 million in Q4 11.
 
Align defers revenue for Invisalign case refinement, which is an optional finishing tool used to adjust a patient's teeth to the desired final position that is generally ordered in the last stages of orthodontic treatment. In Q4 12, we determined that the actual usage rate was lower than our estimate and as a result we released $4.9 million of revenue deferred for case refinement.
 
For fiscal 2012 (FY 12), record net revenues of $560.0 million increased 16.7 percent from $479.7 million reported for fiscal 2011 (FY 11). Record FY 12 Invisalign clear aligner net revenues of $516.6 million increased 14.4% from $451.7 million reported for FY 11. FY 12 Invisalign clear aligner case shipments of 363.5 thousand increased 17.5% from 309.3 thousand reported for FY 11. FY 12 scanner and CAD/CAM services net revenues was $43.4 million compared to $28.0 million in FY 11. FY 11 scanner and CAD/CAM services net revenues reflect eight months of sales resulting from the acquisition of Cadent Holdings, Inc., which closed on April 29, 2011.
 
 
 

 
“I’m very pleased to report a solid fourth quarter which culminated in a record fiscal year for with over 17 percent growth for Invisalign volume”, said Thomas M. Prescott, Align president and CEO. “Despite a soft start this quarter in North America for Align and most of the dental industry, Invisalign case submissions rebounded in December and this trend has continued into the first quarter of 2013.  Overall, we’ve seen an uptick in North American case receipts -- reflecting increased patient traffic in our customers’ offices, as well as traction from customer engagement and practice development activities. We’ve also seen increased customer interest in Invisalign related to the launch of SmartTrack, our next generation aligner material which is commercially available now.”  Prescott continued, “We had many significant accomplishments in 2012 that contributed to our growth, including entry into new market segments with the launch of Invisalign Express 5 and Invisalign i7 and expansion into new emerging country markets.  We are starting off the new year with several new products and feature enhancements including the new iTero scanner, Invisalign Outcome Simulator, and Invisalign G4 enhancements which will contribute to our growth throughout the year.”
 
Net profit for Q4 12 of $9.6 million, or $0.12 per diluted share, includes the release of $4.9 million of revenue previously deferred for Invisalign case refinement. This is compared to net loss of $0.3 million, or $0.00 per diluted share in Q3 12 and net profit of $20.4 million, or $0.25 per diluted share in Q4 11. Net profit for Q4 12 includes a goodwill impairment charge of $11.9 million resulting from finalizing our Q3 12 preliminary estimate and a pre-tax amortization of acquired intangible assets of $1.0 million with a total income tax-related adjustment of $0.2 million. Net loss for Q3 12 includes a preliminary estimate pre-tax goodwill impairment charge of $24.7 million, pre-tax acquisition and integration related costs of $0.2 million, pre-tax amortization of acquired intangible assets of $1.1 million, pre-tax severance and benefit costs of $0.1 million with a total income tax-related adjustment of $2.1 million. Net profit for Q4 11 includes pre-tax acquisition and integration related costs of $1.1 million, pre-tax amortization of acquired intangible assets of $1.3 million, pre-tax severance and benefit costs of $0.8 million with a total tax effect of $0.7 million.
 
In Q3 12, we determined that there were sufficient indicators of a potential impairment to the goodwill attributed to the scanner and CAD/CAM services reporting unit, therefore we conducted step one of the goodwill impairment analysis and concluded that the goodwill was impaired. Based on our preliminary step two analysis, we recorded an estimated goodwill impairment charge of $24.7 million in Q3 12. In Q4 12, we finalized step two of our analysis and recorded an additional goodwill impairment charge of $11.9 million.
 
Net profit for FY 12 was $58.7 million or $0.71 per diluted share and includes pre-tax goodwill impairment charge of $36.6 million, pre-tax acquisition and integration related costs of $1.3 million, pre-tax amortization of acquired intangible assets of $4.4 million, pre-tax severance and benefit costs of $0.8 million with a total tax effect of $4.9 million. This compares to net profit for FY 11 of $66.7 million, or $0.83 per diluted share and includes pre-tax acquisition and integration related costs of $10.0 million, pre-tax amortization of acquired intangible assets of $3.2 million, pre-tax severance and benefit costs of $1.1 million with a total tax effect of $2.9 million.
 
 
 
 

 
To supplement our consolidated financial statements, we use the following non-GAAP financial measures: non-GAAP gross profit, non-GAAP operating expense, non-GAAP operating margin, non-GAAP net profit, non-GAAP earnings per diluted share, EBITDA and adjusted EBITDA. Detailed reconciliations between GAAP and non-GAAP information are contained in the tables following the financial tables of this release.
 
Non-GAAP net profit for Q4 12 was $22.3 million, or $0.27 per diluted share. This is compared to non-GAAP net profit of $23.7 million, or $0.28 per diluted share in Q3 12 and non-GAAP net profit of $23.0 million, or $0.28 per diluted share in Q4 11. Non-GAAP net profit for FY 12 was $96.7 million, or $1.17 per diluted share. This compares to non-GAAP net profit for FY 11 of $78.1 million, or $0.97 per diluted share.
 
 
   
Q4 12 Operating Results ($M)
 
                   
Key GAAP Operating Results
   
Q4 12
     
Q3 12
     
Q4 11
 
Revenue
 
$
142.8
   
$
136.5
   
$
128.9
 
Clear Aligner
 
$
132.8
   
$
126.7
   
$
118.9
 
Scanner and CAD/CAM Services
 
$
10.0
   
$
9.8
   
$
10.0
 
                         
Gross Margin
   
74.5
%
   
73.5
%
   
74.1
%
Clear Aligner
   
78.8
%
   
77.6
%
   
78.7
%
Scanner and CAD/CAM Services
   
18.5
%
   
20.6
%
   
20.0
%
                         
Operating Expense
 
$
89.4
   
$
95.8
   
$
69.1
 
Operating Margin
   
12.0
%
   
3.3
%
   
20.5
%
Net Profit (Loss)
 
$
9.6
   
$
(0.3
)
 
$
20.4
 
Earnings (Loss) Per Diluted Share (EPS)
 
$
0.12
   
$
(0.00
)
 
$
0.25
 
                         
Key Non-GAAP Operating Results
   
Q4 12
     
Q3 12
     
Q4 11
 
Non-GAAP Gross Margin
   
74.7
%
   
73.7
%
   
74.9
%
Non-GAAP Clear Aligner
   
78.8
%
   
77.6
%
   
78.7
%
Non-GAAP Scanner & CAD/CAM Services
   
20.5
%
   
23.8
%
   
30.0
%
                         
Non-GAAP Operating Expense
 
$
76.6
   
$
70.0
   
$
66.9
 
Non-GAAP Operating Margin
   
21.0
%
   
22.4
%
   
23.0
%
Non-GAAP Net Profit
 
$
22.3
   
$
23.7
   
$
23.0
 
Non-GAAP Earnings Per Diluted Share (EPS)
 
$
0.27
   
$
0.28
   
$
0.28
 
EBITDA
 
$
21.7
   
$
8.5
   
$
30.7
 
Adjusted EBITDA
 
$
33.6
   
$
33.6
   
$
32.6
 
 
                       
 
 
 
 

 
 
Total stock-based compensation expense included in Q4 12 was $6.0 million compared to $5.4 million in Q3 12 and $5.0 million in Q4 11. Stock based compensation expense included in GAAP gross margin in Q4 12, Q3 12 and Q4 11 was $0.5 million. Stock-based compensation expense included in GAAP operating expense in Q4 12 was $5.5 million compared to $4.9 million in Q3 12 and $4.5 million in Q4 11.
 
Liquidity and Capital Resources
As of December 31, 2012, Align Technology had $356.1 million in cash, cash equivalents, and marketable securities compared to $248.1 million as of December 31, 2011. During Q4 12, we purchased approximately 1.4 million shares of our common stock at an average price of $26.41 per share for a total of approximately $37.0 million. There remains approximately $95.5 million available under the Company's existing stock repurchase authorization.
 
Q1 Fiscal 2013 Business Outlook
For the first quarter of fiscal 2013 (Q1 13), Align Technology expects net revenues to be in a range of $146.0 million to $150.5 million. Invisalign clear aligner case shipments for Q1 13 are expected to be in a range of 95.0 to 97.5 thousand cases, which reflect a year-over-year increase of 11.4% to 14.3%. Earnings per diluted share for Q1 13 is expected to be in a range of $0.21 to $0.23. Starting in fiscal year 2013, amortization of acquired intangible assets will no longer be excluded as a non-GAAP measure. The expense is now included in all periods presented, therefore, excluding it as a non-GAAP measure is no longer meaningful in period-to-period comparisons. A more comprehensive business outlook is available following the financial tables of this release.
 
Align Web Cast and Conference Call
Align Technology will host a conference call today, January 30, 2013 at 4:30 p.m. ET, 1:30 p.m. PT, to review its fourth quarter and fiscal year 2012 results, discuss future operating trends and business outlook. The conference call will also be web cast live via the Internet. To access the web cast, go to the "Events & Presentations" section under Company Information on Align Technology's Investor Relations web site at http://investor.aligntech.com. To access the conference call, please dial 201-689-8261 approximately fifteen minutes prior to the start of the call. An archived audio web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with conference number 406337 followed by #. For international callers, please dial 201-612-7415 and use the same conference number referenced above. The telephonic replay will be available through 5:30 p.m. ET on February 8, 2013.
 
About Align Technology, Inc.
Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.The Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express 10, Invisalign Express 5, Invisalign Lite, and Vivera Retainers. To learn more about Invisalign or to find an Invisalign trained doctor in your area, please visit www.invisalign.com.
 
 
 
 

 
 
Cadent Holdings, Inc. is a subsidiary of Align Technology and is a leading provider of 3D digital scanning solutions for orthodontics and dentistry. The Cadent family of products includes iTero and iOC scanning systems, OrthoCAD iCast and OrthoCAD iRecord. For additional information, please visit www.cadentinc.com.
 
About non-GAAP Financial Measures
To supplement our consolidated financial statements and our business outlook, we use the following non-GAAP financial measures: non-GAAP gross profit, non-GAAP operating expenses, non-GAAP profit from operations, non-GAAP net profit and non-GAAP earnings per share, which exclude, as applicable, acquisition and integration related costs, amortization of acquired intangible assets, severance and benefit costs, impairment of goodwill, and any related income tax-related adjustments, and EBITDA and adjusted EBITDA. The presentation of this financial information is not intended to be considered in isolation, or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.
 
We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our "core operating performance." Management believes that "core operating performance" represents Align's performance in the ordinary, ongoing and customary course of its operations. Accordingly, management excludes from "core operating performance" certain expenditures and other items that may not be indicative of our operating performance including discrete cash and non-cash charges that are infrequent or one-time in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal evaluation of period-to-period comparisons. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and (2) they are provided to and used by our institutional investors and the analyst community to facilitate comparisons with prior and subsequent reporting periods. A reconciliation of the GAAP and non-GAAP financial measures for the quarter and year and a more detailed explanation of each non-GAAP financial measure and its uses are provided in the footnotes to the table captioned "Reconciliation of GAAP to non-GAAP Key Financial Metrics" and "Business Outlook Summary" included at the end of this release.
 
Forward-Looking Statement
This news release, including the tables below, contains forward-looking statements, including statements regarding certain business metrics for the first quarter of 2013, including anticipated net revenue, gross margin, operating expense, operating income, earnings per share, case shipments and cash. Forward-looking statements contained in this news release and the tables below relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement. Factors that might cause such a difference include, but are not limited to, difficulties predicting customer and consumer purchasing behavior, the willingness and ability of our customers to maintain and/or increase utilization in sufficient numbers, the possibility that the development and release of new products does not proceed in accordance with the anticipated timeline, the possibility that the market for the sale of these new products may not develop as expected, the risks relating to Align's ability to sustain or increase profitability or revenue growth in future periods while controlling expenses, growth related risks, including capacity constraints and pressure on our internal systems and personnel, our ability to successfully achieve the anticipated benefits from the acquisition of Cadent Holdings, Inc., continued customer demand for our existing and new products, changes in consumer spending habits as a result of, among other things, prevailing economic conditions, levels of employment, salaries and wages and consumer confidence, the timing of case submissions from our doctors within a quarter, acceptance of our products by consumers and dental professionals, foreign operational, political and other risks relating to Align's international manufacturing operations, Align's ability to protect its intellectual property rights, continued compliance with regulatory requirements, competition from existing and new competitors, Align's ability to develop and successfully introduce new products and product enhancements, the loss of key personnel and impairments in the book value of goodwill or other intangible assets. These and other risks are detailed from time to time in Align's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, its Annual Report on Form 10-K for the fiscal year ended December 31, 2011, which was filed with the Securities and Exchange Commission on February 29, 2012. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
 
 
 
 

 
 
ALIGN TECHNOLOGY, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
                         
   
Three Months Ended
   
Year Ended
 
   
December 31,
2012
   
December 31,
2011
   
December 31,
2012
   
December 31,
2011
 
                         
Net revenues
 
$
142,840
     
128,905
   
$
560,041
     
479,741
 
                                 
Cost of revenues
   
36,362
     
33,355
     
143,653
     
118,458
 
                                 
Gross profit
   
106,478
     
95,550
     
416,388
     
361,283
 
                                 
Operating expenses:
                               
  Sales and marketing
   
37,769
     
36,112
     
152,041
     
142,174
 
  General and administrative
   
27,166
     
22,457
     
95,840
     
89,152
 
  Research and development
   
11,711
     
9,568
     
42,869
     
37,154
 
  Impairment of goodwill
   
11,926
     
-
     
36,591
     
-
 
  Amortization of acquired intangible assets
   
835
     
983
     
3,455
     
2,443
 
Total operating expenses
   
89,407
     
69,120
     
330,796
     
270,923
 
                                 
Profit from operations
   
17,071
     
26,430
     
85,592
     
90,360
 
                                 
Interest and other income (expense), net
   
(672
)
   
(84
)
   
(1,296
)
   
(419
)
                                 
Profit before income taxes
   
16,399
     
26,346
     
84,296
     
89,941
 
                                 
Provision for income taxes
   
6,840
     
5,897
     
25,605
     
23,225
 
                                 
Net profit
 
$
9,559
   
$
20,449
   
$
58,691
   
$
66,716
 
                                 
Net profit per share
                               
  - basic
 
$
0.12
   
$
0.26
   
$
0.73
   
$
0.86
 
  - diluted
 
$
0.12
   
$
0.25
   
$
0.71
   
$
0.83
 
                                 
Shares used in computing net profit per share
                               
  - basic
   
81,043
     
78,737
     
80,528
     
77,988
 
  - diluted
   
82,981
     
80,849
     
83,040
     
80,294
 
                                 

 
 

 
 
ALIGN TECHNOLOGY, INC.
 
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
 
(in thousands)
 
             
   
December 31,
2012
   
December 31,
2011
 
             
ASSETS
           
             
Current assets:
           
Cash and cash equivalents
  $ 306,386     $ 240,675  
Restricted cash
    1,575       4,026  
Marketable securities, short-term
    28,485       7,395  
Accounts receivable, net
    98,992       91,537  
Inventories
    15,122       9,402  
Other current assets
    35,233       31,781  
Total current assets
    485,793       384,816  
                 
Marketable securities, long-term
    21,252       -  
Property and equipment, net
    79,191       53,965  
Goodwill and intangible assets, net
    145,013       185,405  
Deferred tax assets
    21,609       22,337  
Other long-term assets
    3,454       2,741  
                 
Total assets
  $ 756,312     $ 649,264  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
                 
Current liabilities:
               
Accounts payable
  $ 19,549     $ 19,265  
Accrued liabilities
    74,247       76,600  
Deferred revenue
    65,239       52,252  
Total current liabilities
    159,035       148,117  
                 
Other long term liabilities
    15,960       10,366  
                 
Total liabilities
    174,995       158,483  
                 
Total stockholders' equity
    581,317       490,781  
                 
Total liabilities and stockholders' equity
  $ 756,312     $ 649,264  
                 

 
 

 
 
ALIGN TECHNOLOGY, INC.
RECONCILIATION OF GAAP TO NON-GAAP KEY FINANCIAL METRICS
                 
                 
                 
Reconciliation of GAAP to Non-GAAP Gross Profit
               
(in thousands)
               
   
Three Months Ended
   
December 31,
2012
   
September 30,
2012
   
December 31,
2011
                 
GAAP Gross profit
 
$
106,478
   
$
100,350
   
$
95,550
 
Acquisition and integration costs related to cost of revenues (1)
   
-
     
55
     
139
 
Amortization of acquired intangible assets related to
cost of revenues (2)
   
201
     
213
     
285
 
Severance and benefit costs related to cost of revenues(3)
   
-
     
39
     
579
Non-GAAP Gross profit
 
$
106,679
   
$
100,657
   
$
96,553
 
Reconciliation of GAAP to Non-GAAP Gross Profit Scanner and CAD/CAM Services
                       
(in thousands)
                       
     
Three Months Ended
 
     
December 31,
2012
     
September 30,
2012
     
December 31,
2011
 
                         
GAAP Scanner and CAD/CAM Services gross profit
 
$
1,848
   
$
2,016
   
$
1,993
 
 
Acquisition and integration costs related to cost of revenues (1)
   
-
     
55
     
139
 
 
Amortization of acquired intangible assets related to cost of revenues (2)
   
201
     
213
     
285
 
 
Severance and benefit costs related to cost of revenues(3)
   
-
     
39
     
579
 
Non-GAAP Gross profit
 
$
2,049
   
$
2,323
   
$
2,996
 
                         
Reconciliation of GAAP to Non-GAAP Operating Expenses
                     
(in thousands)
                     
     
Three Months Ended
     
December 31, 2012
     
September 30, 2012
     
December 31, 2011
                       
GAAP Operating expenses
 
$
89,407
   
$
95,847
   
$
69,120
 
Acquisition and integration costs related to operating expenses (1)
   
-
     
(179
)
   
(1,005
 
Amortization of acquired intangible assets related to operating expenses (2)
   
(835
)
   
(866
)
   
(983
 
Severance and benefit costs related to operating expenses (3)
   
-
     
(105
)
   
(256
 
Impairment of goodwill (4)
   
(11,926
)
   
(24,665
)
   
-
Non-GAAP Operating expenses
 
$
76,646
   
$
70,032
   
$
66,876
 
Reconciliation of GAAP to Non-GAAP Profit from Operations
                       
(in thousands)
                       
     
Three Months Ended
 
     
December 31, 2012
     
September 30, 2012
     
December 31, 2011
 
                         
GAAP Profit from operations
 
$
17,071
   
$
4,503
   
$
26,430
 
 
Acquisition and integration costs (1)
   
-
     
234
     
1,144
 
 
Amortization of acquired intangible assets (2)
   
1,036
     
1,079
     
1,268
 
 
Severance and benefit costs (3)
   
-
     
144
     
835
 
 
Impairment of goodwill
   
11,926
     
24,665
     
-
 
Non-GAAP Profit from operations
 
$
30,033
   
$
30,625
   
$
29,677
 
                         
 
Reconciliation of GAAP to Non-GAAP Net Profit
                       
(in thousands, except per share amounts)
                       
     
Three Months Ended
 
     
December 31, 2012
     
September 30, 2012
     
December 31, 2011
 
                         
GAAP Net profit (loss)
 
$
9,559
   
$
(344
)
 
$
20,449
 
 
Acquisition and integration costs (1)
   
-
     
234
     
1,144
 
 
Amortization of acquired intangible assets (2)
   
1,036
     
1,079
     
1,268
 
 
Severance and benefit costs (3)
   
-
     
144
     
835
 
 
Impairment of goodwill (4)
   
11,926
     
24,665
     
-
 
 
Income tax-related adjustments (5)
   
(193
)
   
(2,078
)
   
(715
)
Non-GAAP Net profit
 
$
22,328
   
$
23,700
   
$
22,981
 
                         
Diluted Net profit (loss) per share:
                       
   
GAAP
 
$
0.12
   
$
(0.00
)
 
$
0.25
 
   
Non-GAAP
 
$
0.27
   
$
0.28
   
$
0.28
 
                         
Shares used in computing diluted GAAP Net profit (loss) per share
   
82,981
     
81,437
     
80,849
 
Shares used in computing diluted Non-GAAP Net profit per share
   
82,981
     
83,906
     
80,849
 
 
Reconciliation of GAAP Net Profit to EBITDA and Adjusted EBITDA
                       
(in thousands)
                       
     
Three Months Ended
 
     
December 31, 2012
     
September 30, 2012
     
December 31, 2011
 
                         
GAAP Net profit (loss)
 
$
9,559
   
$
(344
)
 
$
20,449
 
Provision for income taxes
   
6,840
     
4,494
     
5,897
 
Depreciation and amortization (6)
   
5,278
     
4,374
     
4,320
 
EBITDA (7)
   
21,677
     
8,524
     
30,666
 
                         
Adjustments or charges:
                       
 
Acquisition and integration related costs (1)
   
-
     
234
     
1,144
 
 
Severance and benefit costs (3)
   
-
     
144
     
835
 
 
Impairment of goodwill (4)
   
11,926
     
24,665
     
-
 
EBITDA after adjustments (7)
 
$
33,603
   
$
33,567
   
$
32,645
 
 

 
 
 

 
 
ALIGN TECHNOLOGY, INC.      
RECONCILIATION OF GAAP TO NON-GAAP KEY FINANCIAL METRICS      
 
Reconciliation of GAAP to Non-GAAP Gross Profit      
(in thousands)      
   
Year Ended
 
   
December 31, 2012
   
December 31, 2011
 
                 
GAAP Gross profit
 
$
416,388
   
$
361,283
 
 
Acquisition and integration costs related to cost of revenues (1)
   
261
     
398
 
 
Amortization of acquired intangible assets related to cost of revenues (2)
   
907
     
735
 
 
Severance and benefit costs related to cost of revenues (3)
   
474
     
754
 
Non-GAAP Gross profit
 
$
418,030
   
$
363,170
 
                 
Reconciliation of GAAP to Non-GAAP Gross Profit Scanner and CAD/CAM Services
               
(in thousands)
               
     
Year Ended
 
     
December 31, 2012
     
December 31, 2011
 
                 
GAAP Scanner and CAD/CAM Services gross profit
 
$
10,418
   
$
6,640
 
 
Acquisition and integration costs related to cost of revenues (1)
   
261
     
398
 
 
Amortization of acquired intangible assets related to cost of revenues (2)
   
907
     
735
 
 
Severance and benefit costs related to cost of revenues(3)
   
474
     
754
 
Non-GAAP Gross profit
 
$
12,060
   
$
8,527
 
                 
Reconciliation of GAAP to Non-GAAP Operating Expenses
               
(in thousands)
               
     
Year Ended
 
     
December 31, 2012
     
December 31, 2011
 
                 
GAAP Operating expenses
 
$
330,796
   
$
270,923
 
 
Acquisition and integration costs related to operating expenses (1)
   
(1,010
)
   
(9,632
)
 
Amortization of acquired intangible assets related to operating expenses (2)
   
(3,455
)
   
(2,443
)
 
Severance and benefit costs related to operating expenses (3)
   
(306
)
   
(328
)
 
Impairment of goodwill (4)
   
(36,591
)
   
-
 
Non-GAAP Operating expenses
 
$
289,434
   
$
258,520
 
 
Reconciliation of GAAP to Non-GAAP Profit from Operations
               
(in thousands)
               
     
Year Ended
 
     
December 31, 2012
     
December 31, 2011
 
                 
GAAP Profit from Operations
 
$
85,592
   
$
90,360
 
 
Acquisition and integration costs related to cost of revenues (1)
   
1,271
     
10,030
 
 
Amortization of acquired intangible assets related to cost of revenues (2)
   
4,362
     
3,178
 
 
Severance and benefit costs related to cost of revenues (3)
   
780
     
1,082
 
 
Impairment of goodwill (4)
   
36,591
     
-
 
Non-GAAP Profit from Operations
 
$
128,596
   
$
104,650
 
 
Reconciliation of GAAP to Non-GAAP Net Profit
               
(in thousands, except per share amounts)
               
     
Year Ended
 
     
December 31, 2012
     
December 31, 2011
 
                 
GAAP Net profit
 
$
58,691
   
$
66,716
 
 
Acquisition and integration costs related to cost of revenues (1)
   
1,271
     
10,030
 
 
Amortization of acquired intangible assets related to cost of revenues (2)
   
4,362
     
3,178
 
 
Severance and benefit costs related to cost of revenues (3)
   
780
     
1,082
 
 
Impairment of goodwill (4)
   
36,591
     
-
 
 
Tax effect on non-GAAP adjustments (5)
   
(4,947
)
   
(2,862
)
Non-GAAP Net profit
 
$
96,748
   
$
78,144
 
                 
Diluted Net profit per share:
               
   
GAAP
 
$
0.71
   
$
0.83
 
   
Non-GAAP
 
$
1.17
   
$
0.97
 
                 
Shares used in computing diluted GAAP net profit per share
   
83,040
     
80,294
 
Shares used in computing diluted non-GAAP net profit per share
   
83,040
     
80,294
 
 
Reconciliation of GAAP Net Profit to EBITDA and Adjusted EBITDA
               
(in thousands)
               
     
Year Ended
 
     
December 31, 2012
     
December 31, 2011
 
                 
GAAP Net profit
 
$
58,691
   
$
66,716
 
Provision for income taxes
   
25,605
     
23,225
 
Depreciation and amortization (6)
   
17,811
     
17,477
 
EBITDA (7)
   
102,107
     
107,418
 
                 
Adjustments or charges:
               
 
Acquisition and integration related costs (1)
   
1,271
     
10,030
 
 
Severance and benefit costs (3)
   
780
     
1,082
 
 
Impairment of goodwill (4)
   
36,591
     
-
 
EBITDA after adjustments (7)
 
$
140,749
   
$
118,530
 
 
 

 
 
(1) Acquisition costs and integration related. We have incurred acquisition-related and other expenses which include legal, banker, accounting and other advisory fees of third parties, retention bonuses, integration and professional fees. We do not engage in acquisitions in the ordinary course of business. We believe that it is important to understand these charges; however, we do not believe that these charges are indicative of future operating results. We believe that eliminating these expenses from our non-GAAP measures is useful because we generally would not have otherwise incurred such expenses in the periods presented as part of our continuing operations.
 
(2) Amortization of acquired intangible assets. When conducting internal development of intangible assets (including developed technology, customer relationships, trademarks, etc.), GAAP accounting rules require that we expense the costs as incurred. In the case of acquired businesses, however, we are required to allocate a portion of the purchase price to the accounting value assigned to intangible assets acquired and amortize this amount over the estimated useful lives of the acquired intangibles. The acquired company, in most cases, has itself previously expensed the costs incurred to develop the acquired intangible assets, and the purchase price allocated to these assets is not necessarily reflective of the cost we would incur in developing the intangible asset. We eliminate these amortization charges for our non-GAAP operating results to provide better comparability of pre and post-acquisition operating results and comparability to results of businesses utilizing internally developed intangible assets.
 
(3) Severance and benefits costs. These costs are related to the closure of our New Jersey operations and were realized through the first three quarters of 2012. We have engaged in various restructuring and exit activities in 2011 and 2009 that have resulted in costs associated with severance and benefits. Such activity has been a discrete event based on a unique set of business objectives or circumstances, and each has differed from the others in terms of its operational implementation, business impact and scope. We do not engage in restructuring and/or exit activities in the ordinary course of business. We believe that it is important to understand significant severance and benefits costs and, we believe that investors benefit from excluding these charges from our operating results to facilitate a more meaningful evaluation of current operating performance and comparisons to past operating performance.
 
(4) Impairment of goodwill. This cost represents non-cash write-downs of our goodwill. During the third quarter of 2012, we determined that there were sufficient indicators such as the termination of our distribution agreement with Straumann for iTero intra-oral scanners as well as the market conditions and business trends within our Scanners and CAD/CAM Services reporting unit for an impairment of goodwill. We remove the impact of these charges to our operating performance to assist in assessing our ability to generate cash from operations. We believe this may be useful information to users of our financial statements and therefore we have excluded these charges for purposes of calculating these non-GAAP measures to facilitate an evaluation of our current operating performance, particularly in terms of liquidity.
 
(5) Income tax-related adjustments. Non-GAAP financial information for the quarter is adjusted for a tax rate equal to our annual estimated tax rate on non-GAAP income. This rate is based on our estimated annual GAAP income tax rate forecast, adjusted to account for discrete tax items and items excluded from GAAP income in calculating the non-GAAP financial measures presented above. Our estimated tax rate on non-GAAP income is determined annually and may be re-calculated during the year to take into account events or trends that we believe materially impact the estimated annual rate.
 
(6) Includes the amortization of acquired intangible assets.
 
(7) EBITDA and adjusted EBITDA. We use EBITDA as a performance measure for benchmarking against our peers and competitors. We believe EBITDA is useful to investors because it is frequently used by securities analysts, investors and other interested parties to evaluate companies in the medical technology industry. We also use adjusted EBITDA which excludes certain special or non-recurring expenses, net of certain special or non-recurring benefits, detailed in the reconciliation tables that accompany this release, as an internal measure of business operating performance. We believe such financial measures provide a meaningful perspective of the underlying operating performance to our current business. EBITDA and adjusted EBITDA are not recognized terms under GAAP. Because all companies do not calculate EBITDA and similarly titled financial measures in the same way, those measures as used by other companies may not be consistent with the way we calculate such measures and should not be considered as alternative measures of operating or net profit.
 
 
 
 

 
 
ALIGN TECHNOLOGY
Q4 2012 EARNINGS RELEASE ADDITIONAL DATA
REVENUE PERFORMANCE AND CLEAR ALIGNER METRICS
(in thousands except per share data)
                               
   
Q1
   
Q2
   
Q3
   
Q4
   
FISCAL
 
   
2012
   
2012
   
2012
   
2012
   
2012
 
Invisalign Clear Aligner Revenues by Geography:
                             
  North America
 
$
86,871
   
$
92,997
   
$
89,568
   
$
91,686
   
$
361,122
 
    North American Orthodontists
   
41,688
     
43,942
     
43,090
     
43,812
     
172,532
 
    North American GP Dentists
   
45,183
     
49,055
     
46,478
     
47,874
     
188,590
 
  International
   
29,700
     
32,883
     
29,700
     
32,513
     
124,796
 
  Non-case*
   
6,757
     
7,789
     
7,457
     
8,660
     
30,663
 
    Total Clear Aligner Revenue
 
$
123,328
   
$
133,669
   
$
126,725
   
$
132,859
   
$
516,581
 
      YoY % growth
   
17.6
%
   
17.6
%
   
10.9
%
   
11.7
%
   
14.4
%
      QoQ % growth
   
3.7
%
   
8.4
%
   
-5.2
%
   
4.8
%
       
*includes Invisalign training, ancillary products, and retainers
                                       
Invisalign Clear Aligner Revenues by Product:
                                       
  Invisalign Full
 
$
82,424
   
$
88,617
   
$
80,294
   
$
87,265
   
$
338,600
 
  Invisalign Express/Lite
   
11,806
     
13,632
     
12,779
     
13,269
     
51,486
 
  Invisalign Teen
   
15,148
     
16,380
     
19,144
     
16,455
     
67,127
 
  Invisalign Assist
   
7,193
     
7,251
     
7,051
     
7,210
     
28,705
 
  Non-case*
   
6,757
     
7,789
     
7,457
     
8,660
     
30,663
 
    Total Clear Aligner Revenue
 
$
123,328
   
$
133,669
   
$
126,725
   
$
132,859
   
$
516,581
 
                                         
Average Invisalign Selling Price (ASP), as billed:
                                       
  Total Worldwide Blended ASP
 
$
1,370
   
$
1,335
   
$
1,320
   
$
1,375
   
$
1,350
 
  International ASP
 
$
1,485
   
$
1,455
   
$
1,355
   
$
1,455
   
$
1,440
 
                                         
Invisalign Clear Aligner Cases Shipped by Geography:
                                       
  North America
   
65,280
     
72,685
     
70,610
     
68,140
     
276,715
 
    North American Orthodontists
   
32,235
     
35,420
     
35,885
     
33,505
     
137,045
 
    North American GP Dentists
   
33,045
     
37,265
     
34,725
     
34,635
     
139,670
 
  International
   
19,985
     
22,595
     
21,905
     
22,340
     
86,825
 
    Total Cases Shipped
   
85,265
     
95,280
     
92,515
     
90,480
     
363,540
 
                                         
Invisalign Clear Aligner Cases Shipped by Product:
                                       
  Invisalign Full
   
57,145
     
62,510
     
57,400
     
57,920
     
234,975
 
  Invisalign Express/Lite
   
12,855
     
15,300
     
14,610
     
15,940
     
58,705
 
  Invisalign Teen
   
9,935
     
11,860
     
15,265
     
11,255
     
48,315
 
  Invisalign Assist
   
5,330
     
5,610
     
5,240
     
5,365
     
21,545
 
    Total Cases Shipped
   
85,265
     
95,280
     
92,515
     
90,480
     
363,540
 
                                         
Number of Invisalign Doctors Cases Shipped to:
                                       
  North American Orthodontists
   
4,460
     
4,575
     
4,660
     
4,615
     
5,665
 
  North American GP Dentists
   
11,365
     
12,120
     
11,925
     
11,685
     
19,285
 
  International
   
5,085
     
5,480
     
5,400
     
5,715
     
9,285
 
    Total Doctors Cases were Shipped to Worldwide
   
20,910
     
22,175
     
21,985
     
22,015
     
34,235
 
                                         
Invisalign Doctor Utilization Rates*:
                                       
  North American Orthodontists
   
7.2
     
7.7
     
7.7
     
7.3
     
24.2
 
  North American GP Dentists
   
2.9
     
3.1
     
2.9
     
3.0
     
7.2
 
  International
   
3.9
     
4.1
     
4.1
     
3.9
     
9.4
 
    Total Utilization Rates
   
4.1
     
4.3
     
4.2
     
4.1
     
10.6
 
  * # of cases shipped/# of doctors to whom cases were shipped
                                       
Number of Invisalign Doctors Trained:
                                         
  North American Orthodontists
   
90
     
95
     
125
     
75
     
385
 
  North American GP Dentists
   
720
     
995
     
675
     
920
     
3,310
 
  International
   
715
     
965
     
685
     
780
     
3,145
 
  Total Doctors Trained Worldwide
   
1,525
     
2,055
     
1,485
     
1,775
     
6,840
 
  Total to Date Worldwide
   
71,180
     
73,235
     
74,720
     
76,495
     
76,495
 
                                         
Scanner and CAD/CAM Services Revenue:
                                       
  North America Scanner and CAD/CAM Services
 
$
11,120
   
$
11,752
   
$
9,439
   
$
9,940
   
$
42,251
 
  International Scanner and CAD/CAM Services
   
631
     
205
     
332
     
41
     
1,209
 
    Total Scanner and CAD/CAM Revenue
 
$
11,751
   
$
11,957
   
$
9,771
   
$
9,981
   
$
43,460
 
                                         
  Scanner Revenue
 
$
5,361
   
$
6,032
   
$
4,023
   
$
4,643
   
$
20,059
 
  CAD/CAM Services Revenue
   
6,390
     
5,925
     
5,748
     
5,338
     
23,401
 
    Total Scanner and CAD/CAM Services Revenue
 
$
11,751
   
$
11,957
   
$
9,771
   
$
9,981
   
$
43,460
 
                                         
Total Revenue by Geography:
                                       
  Total North America Revenue
 
$
97,991
   
$
104,749
   
$
99,007
   
$
101,626
   
$
403,373
 
  Total International Revenue
   
30,331
     
33,088
     
30,032
     
32,554
     
126,005
 
  Total Non-case Revenue
   
6,757
     
7,789
     
7,457
     
8,660
     
30,663
 
    Total Worldwide Revenue
 
$
135,079
   
$
145,626
   
$
136,496
   
$
142,840
   
$
560,041
 
      YoY % growth
   
28.8
%
   
21.3
%
   
8.4
%
   
10.8
%
   
16.7
%
      QoQ % growth
   
4.8
%
   
7.8
%
   
-6.3
%
   
4.6
%
       

Note: Historical public data may differ due to rounding. Additionally, rounding may effect totals.
 
 

 
 

 
 
ALIGN TECHNOLOGY, INC.
   
BUSINESS OUTLOOK SUMMARY
   
(unaudited)
   
     
The outlook figures provided below and elsewhere in this press release are approximate in nature since Align's business outlook is difficult to predict. Align's future performance involves numerous risks and uncertainties and the company's results could differ materially from the outlook provided. Some of the factors that could affect Align's future financial performance and business outlook are set forth under "Forward Looking Information" above in this press release.
 
Financials
   
(in millions, except per share amounts and percentages)
     
   
Q1 2013
     
Net Revenue
 
$146.0 - $150.5
     
Gross Profit
 
$105.8 - $110.1
     
Gross Margin
 
72.4% - 73.1%
     
Operating Expenses
 
$82.8 - $84.4
     
Operating Margin
 
15.8% - 17.1%
     
Net Income per Diluted Share
 
$0.21 - $0.23
     
Stock Based Compensation Expense:
   
Cost of Revenues
 
$0.7
Operating Expenses
 
$6.3
Total Stock Based Compensation Expense
 
$7.0
     
Business Metrics:
   
   
Q1 2013
Case Shipments
 
95.0K - 97.5K
Cash, Cash Equivalents, and Marketable Securities
 
$365M - $375M *
Capex
 
$3.5M - $5.0M
Depreciation & Amortization
 
$4.5M - $5.0M
Diluted Shares Outstanding
 
83.2M*

* Excludes any stock repurchases during the quarter
 
Investor Relations Contact
Shirley Stacy
Align Technology, Inc.
(408) 470-1150

sstacy@aligntech.com
 
Press Contact
Shannon Mangum Henderson
Ethos Communication, Inc.
(678) 261-7803

align@ethoscommunication.com
 


 
 

The following information was filed by Align Technology Inc (ALGN) on Wednesday, January 30, 2013 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Align Technology Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Align Technology Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account